Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
The Israel Medical Association Journal : IMAJ
|
February 28, 2008
The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model
Sara Fuchs, Tali Feferman, Roberto Meidler, et al.
Journal of Neuroimmunology
|
August 8, 2008
Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
Talma Brenner, Eran Nizri, Michal Irony-Tur-Sinai, et al.
Central Nervous System Agents in Medicinal Chemistry
|
August 31, 2016
Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Millet Treinin, Roger L Papke, Eran Nizri, et al.
Pharmacology
|
December 2, 2006
Novel approaches to treatment of autoimmune neuroinflammation and lessons for drug development
Eran Nizri, Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, et al.
International Immunopharmacology
|
July 17, 2007
IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity
Eran Nizri, Michal Irony-Tur-Sinai, Iris Lavon, et al.
Journal of Autoimmunity
|
January 16, 2014
Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential
Devorah Gur-Wahnon, Tehila Mizrachi, Shane Wald-Altman, et al.
Journal of the Neurological Sciences
|
January 28, 2009
Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3
Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, Dimitrios Tsiantoulas, et al.
Acta Neurologica Scandinavica
|
March 8, 2020
Incidence of AChR Ab-positive myasthenia gravis in Israel: A population-based study
Itay Lotan, Felix Benninger, Mark A Hellmann, et al.
Molecular Brain
|
May 1, 2016
RIC-3 expression and splicing regulate nAChR functional expression
Yael Ben-David, Tehila Mizrachi, Sarah Kagan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 2009
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses
Eran Nizri, Michal Irony-Tur-Sinai, Omer Lory, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
The Israel Medical Association Journal : IMAJ
|
February 28, 2008
The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model
Sara Fuchs, Tali Feferman, Roberto Meidler, et al.
Journal of Neuroimmunology
|
August 8, 2008
Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
Talma Brenner, Eran Nizri, Michal Irony-Tur-Sinai, et al.
Central Nervous System Agents in Medicinal Chemistry
|
August 31, 2016
Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Millet Treinin, Roger L Papke, Eran Nizri, et al.
Pharmacology
|
December 2, 2006
Novel approaches to treatment of autoimmune neuroinflammation and lessons for drug development
Eran Nizri, Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, et al.
International Immunopharmacology
|
July 17, 2007
IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity
Eran Nizri, Michal Irony-Tur-Sinai, Iris Lavon, et al.
Journal of Autoimmunity
|
January 16, 2014
Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential
Devorah Gur-Wahnon, Tehila Mizrachi, Shane Wald-Altman, et al.
Journal of the Neurological Sciences
|
January 28, 2009
Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3
Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, Dimitrios Tsiantoulas, et al.
Acta Neurologica Scandinavica
|
March 8, 2020
Incidence of AChR Ab-positive myasthenia gravis in Israel: A population-based study
Itay Lotan, Felix Benninger, Mark A Hellmann, et al.
Molecular Brain
|
May 1, 2016
RIC-3 expression and splicing regulate nAChR functional expression
Yael Ben-David, Tehila Mizrachi, Sarah Kagan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 2009
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses
Eran Nizri, Michal Irony-Tur-Sinai, Omer Lory, et al.
Page
of 5